GlobalOptions Group Completes Sale of its Forensic DNA Solutions and Products Unit

Wall Street Journal Market Watch
NEW YORK, Dec 01, 2010 (BUSINESS WIRE) — GlobalOptions Group, Inc. /quotes/comstock/15*!gloi/quotes/nls/gloi (GLOI 2.36, -0.03, -1.26%) has completed the sale of the stock of The Bode Technology Group, Inc. (“Bode”), its Forensic DNA Solutions and Products subsidiary, to SolutionPoint International, Inc. for a total aggregate consideration of up to $30.5 million.